What does Hainan Huluwa Pharmaceutical Group Co., Ltd. do?

Hainan Huluwa Pharmaceutical Group Co., Ltd. (605199.SS) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 605199.SS's market cap?

Hainan Huluwa Pharmaceutical Group Co., Ltd. (605199.SS) has a market capitalization of approximately $2.42 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 605199.SS pay a dividend?

Yes — Hainan Huluwa Pharmaceutical Group Co., Ltd. (605199.SS) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.

Is 605199.SS profitable?

Hainan Huluwa Pharmaceutical Group Co., Ltd. (605199.SS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

605199.SS

Hainan Huluwa Pharmaceutical Group Co., Ltd.

SHH·Medical, Pharmaceuticals · Healthcare

¥6.04¥0.04+0.67%

Market cap¥2.42B·Market closed·Aug 26 7:00 AM UTC

Price Chart

¥6.04+¥0.04 (+0.67%)today

−71.40%CAGR −22.15%

Select date range

FromTo

Jul 10, 2020Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)0.00%

Annual Dividend (FWD)¥0.00

Dividend Growth (5Y)—

Dividend Safety—

Payout Ratio—

FCF Payout Ratio—

Most Recent Dividend¥0.125

Ex-Dividend DateJul 16

Payment DateJul 16

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateAug 28

Last Report DateSep 29

Reported vs Estimate−¥0.03

Earnings Surprise—

FinancialsFinancials Tab

Revenue¥710.14M

Net Income−¥340.68M

Net Margin−48.0%

Operating Cash Flow¥297.36M

Capital Expenditures¥52.07M

Free Cash Flow¥245.29M

Return on Equity−88.8%

Return on Invested Capital−1.7%

Net Debt¥966.43M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 605199.SS and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 605199.SS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 605199.SS and 80,000+ other tickers.

About Hainan Huluwa Pharmaceutical Group Co., Ltd.

Hainan Huluwa Pharmaceutical Group Co., Ltd. research, develops, produces, and sells drugs in the areas of Children's digestive system, respiratory system, anti-infection, anti-virus and other fields in China. The company offers pediatrics, gynecology, antibiotics, respiratory, digestive system, cardiovascular and cerebrovascular, nourishment, and other medicine products. Hainan Huluwa Pharmaceutical Group Co., Ltd. was founded in 2005 and is based in Haikou, China.

CEO: Jing Ping Liu
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Exchange: SHH
Employees: 2,103
Website: www.huluwayaoye.com

Peers

Peers Tab

300878.SZ

Zhejiang Wecome Pharmaceutical Company Limited

Cap

¥4.6B

002286.SZ

Baolingbao Biology Co.,Ltd.

Cap

¥3.0B

688317.SS

Shanghai ZJ Bio-Tech Co., Ltd.

Cap

¥3.3B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 605199.SS

What does Hainan Huluwa Pharmaceutical Group Co., Ltd. do?: Hainan Huluwa Pharmaceutical Group Co., Ltd. (605199.SS) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 605199.SS's market cap?: Hainan Huluwa Pharmaceutical Group Co., Ltd. (605199.SS) has a market capitalization of approximately $2.42 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 605199.SS pay a dividend?: Yes — Hainan Huluwa Pharmaceutical Group Co., Ltd. (605199.SS) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.
Is 605199.SS profitable?: Hainan Huluwa Pharmaceutical Group Co., Ltd. (605199.SS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.